Heparin is an anticoagulant medication and a naturally occurring glycosaminoglycan produced by basophils and mast cells in all mammals. It is used to prevent formation of blood clots caused by certain ...
Tinzaparin is a low-molecular-weight heparin (LMWH) with antithrombotic properties. It has FDA-approved labeling for use in the treatment of acute symptomatic deep-vein thrombosis (DVT ...
A brief overview of the pathophysiology, diagnosis, and treatment of heparin-induced thrombocytopenia (HIT) is discussed. Following any exposure to unfractionated heparin or low-molecular-weight ...
13d
MedPage Today on MSNBlood Clot Prevention in Fracture Patients: No Difference for Aspirin vs LMWHSAN DIEGO -- For patients with traumatic bone fractures, there was no difference between oral aspirin and low-molecular-weight heparin (LMWH) injections as a bleeding prevention strategy, a ...
The Chinese Medical Association has released new guidelines for diagnosing and treating Mycoplasma pneumoniae in children.
"Previous studies have demonstrated that using low-molecular weight heparins to prevent DVT is ineffective, probably due to the insufficient blood circulation during lower leg immobilization.
Mycoplasma pneumoniae pneumonia (MPP) is a bacterial pathogen that causes pneumonia in school-aged children and adolescents.
Complexity of Serpiginous Right Atrium Thrombus Management in Acute Pulmonary Embolism Patient: A Clinical Case Report. World Journal of Cardiovascular Diseases, 15, 135-141. doi: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results